GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » Piotroski F-Score

Veritas In Silico (TSE:130A) Piotroski F-Score : 7 (As of Jan. 18, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Veritas In Silico Piotroski F-Score?

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Veritas In Silico has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Veritas In Silico's Piotroski F-Score or its related term are showing as below:

TSE:130A' s Piotroski F-Score Range Over the Past 10 Years
Min: 7   Med: 7   Max: 7
Current: 7

During the past 3 years, the highest Piotroski F-Score of Veritas In Silico was 7. The lowest was 7. And the median was 7.


Veritas In Silico Piotroski F-Score Historical Data

The historical data trend for Veritas In Silico's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veritas In Silico Piotroski F-Score Chart

Veritas In Silico Annual Data
Trend Dec21 Dec22 Dec23
Piotroski F-Score
N/A N/A 7.00

Veritas In Silico Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24
Piotroski F-Score Get a 7-Day Free Trial N/A - 7.00 - -

Competitive Comparison of Veritas In Silico's Piotroski F-Score

For the Biotechnology subindustry, Veritas In Silico's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veritas In Silico's Piotroski F-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Veritas In Silico's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Veritas In Silico's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was 円33.0 Mil.
Cash Flow from Operations was 円68.7 Mil.
Revenue was 円360.4 Mil.
Gross Profit was 円360.4 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was (1598.576 + 1655.531) / 2 = 円1627.0535 Mil.
Total Assets at the begining of this year (Dec22) was 円1,598.6 Mil.
Long-Term Debt & Capital Lease Obligation was 円0.0 Mil.
Total Current Assets was 円1,629.2 Mil.
Total Current Liabilities was 円79.9 Mil.
Net Income was 円-141.4 Mil.

Revenue was 円178.8 Mil.
Gross Profit was 円178.8 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was (1754.789 + 1598.576) / 2 = 円1676.6825 Mil.
Total Assets at the begining of last year (Dec21) was 円1,754.8 Mil.
Long-Term Debt & Capital Lease Obligation was 円0.0 Mil.
Total Current Assets was 円1,547.2 Mil.
Total Current Liabilities was 円56.0 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Veritas In Silico's current Net Income (TTM) was 33.0. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Veritas In Silico's current Cash Flow from Operations (TTM) was 68.7. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=33.048/1598.576
=0.0206734

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-141.381/1754.789
=-0.08056866

Veritas In Silico's return on assets of this year was 0.0206734. Veritas In Silico's return on assets of last year was -0.08056866. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Veritas In Silico's current Net Income (TTM) was 33.0. Veritas In Silico's current Cash Flow from Operations (TTM) was 68.7. ==> 68.7 > 33.0 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=0/1627.0535
=0

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=0/1676.6825
=0

Veritas In Silico's gearing of this year was 0. Veritas In Silico's gearing of last year was 0. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=1629.208/79.892
=20.39263005

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=1547.181/55.986
=27.63514093

Veritas In Silico's current ratio of this year was 20.39263005. Veritas In Silico's current ratio of last year was 27.63514093. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Veritas In Silico's number of shares in issue this year was 5.501. Veritas In Silico's number of shares in issue last year was 5.501. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=360.356/360.356
=1

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=178.801/178.801
=1

Veritas In Silico's gross margin of this year was 1. Veritas In Silico's gross margin of last year was 1. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=360.356/1598.576
=0.22542313

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=178.801/1754.789
=0.10189316

Veritas In Silico's asset turnover of this year was 0.22542313. Veritas In Silico's asset turnover of last year was 0.10189316. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+0+1+0+1
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Veritas In Silico has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Veritas In Silico  (TSE:130A) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Veritas In Silico Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Veritas In Silico's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Veritas In Silico Business Description

Traded in Other Exchanges
N/A
Address
1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.

Veritas In Silico Headlines

No Headlines